Key result
Baseline depressive symptoms linked to ~18% higher cardiovascular mortality in heart failure patients.
Why the study?
Depression symptoms are common among heart failure patients, but there is little consensus regarding the relationship between depressive symptoms and NT-proBNP.
Do depressive symptoms correlate with NT-proBNP levels, health status, and cardiovascular mortality in patients with heart failure?
Cohort (n=151)
Do depressive symptoms correlate with NT-proBNP levels, health status, and cardiovascular mortality in patients with heart failure?
Effect estimate: HR 1.18 (95% CI 1.0 - 1.4)
p-value: p=0.048
Depressive symptoms in heart failure patients are significantly correlated with higher NT-proBNP, worse health status, and an increased risk of cardiovascular mortality.
Depressive symptoms may identify higher-risk HF patients; leaves open whether treatment reduces cardiovascular mortality.
Background: Although depression symptoms are common among heart failure (HF) patients, there is little consensus regarding the relationship between depressive symptoms and NT-proBNP, the key HF marker. Therefore, this study aimed to investigate this relationship and assess the impact of depressive symptoms on the health status and clinical outcomes of HF patients. Methods: 151 patients with HF were enrolled in the study and followed up for one year. Depressive symptoms and health status were assessed by the Hospital Anxiety and Depression Scale (HADS-D) and the Kansas City Cardiomyopathy Questionnaire (KCCQ), respectively. Results: At baseline, the median HADS-D score was 5 (3 - 8) points. Patients with HADS-D scores > 5 points had significantly higher NT-proBNP levels ( p = 0.043), and significantly lower KCCQ-OSS and KCCQ-CSS ( p < 0.001 for both KCCQ scores). From baseline to the last assessment after one year the percentage changes in the HADS-D scores were significantly positively correlated with the percentage changes in the levels of NT-proBNP (r = 0.22, p = 0.009). It was also significantly negatively correlated with the changes in KCCQ-OSS (r = -0.34, p < 0.001) and KCCQ-CSS (r = -0.19, p = 0.021). Moreover, baseline HADS-D score was an independent predictor of the percentage changes in NT-proBNP from baseline to the last assessment (ß = 3.91, p = 0.03), even after adjustment for age, sex, baseline LVEF and creatinine (ß = 3.99, p = 0.02). In a Cox regression analysis baseline HADS-D score had a significant impact on the cardiovascular mortality, which remained consistent even after adjustment for age, sex, and baseline LVEF, NT-proBNP and creatinine (hazard ratio = 1.18, 95% CI = 1.0 – 1.4, p = 0.048). Conclusions: 1. There is a significant correlation between depressive symptoms, NT-proBNP, and health status in HF patients. 2. Baseline HADS-D score has a significant impact on the cardiovascular mortality in HF patients.
No takes yet. Share an insight, caveat, or question.
Balata et al. (2023) conducted a cohort in Heart failure (n=151). Depressive symptoms (HADS-D score) was evaluated on Cardiovascular mortality (HR 1.18, 95% CI 1.0 - 1.4, p=0.048). Baseline depressive symptoms significantly predicted cardiovascular mortality in heart failure patients (HR 1.18; 95% CI 1.0-1.4; p=0.048).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: